• A leading diagnostics company sought to accelerate clinical and biomarker research by integrating 175M+ EHR, imaging, and molecular assay records from multiple sources into a unified platform. Their objective was to streamline data harmonization and enhance AI-driven insights for new product development.
• The company faced challenges in harmonizing 100M EHR records, 50M imaging records, and 25M omics datasets spanning over a decade. ‍
• Elucidata’s Polly, the only AI-ready Clinical Data Platform, was deployed to provide a holistic view of patient information, filled this need, thereby enabling researchers to gain deeper insights and accelerate new biomarker discovery.
• The implementation of Polly resulted in 4X lower costs for multi-modal data product generation, 2X faster AI model development, and over 1,500 hours of manual effort saved. Additionally, Polly achieved 99.99% data accuracy, enabling faster clinical research and biomarker discovery.

‍